Bill > HR661

This bill establishes a comprehensive program to enhance medical technology collaboration between the United States and Israel, aimed at advancing healthcare innovation and cooperation. The Secretary of Health and Human Services, in consultation with other government agencies, will coordinate efforts across multiple key areas including joint research and development projects, support for medical startups, regulatory harmonization, and intellectual property protection. Specific focus areas include developing medical devices, pharmaceuticals, digital health solutions, and biological products, with special attention to early-stage clinical trials, technology transfer, and collaborative research. The program will facilitate sharing of best practices, promote telemedicine infrastructure, support disease prevention initiatives, and establish mechanisms for joint manufacturing of biological products. The bill authorizes the potential creation of a United States-Israel Health Care Collaboration Center and allocates $8 million annually from fiscal years 2026 through 2030 to implement these initiatives. The program aims to leverage the technological expertise of both countries, enhance healthcare system capabilities, and accelerate the development of innovative medical technologies and treatments while promoting cybersecurity, patient privacy, and supply chain resilience.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/661/all-info